패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처는 미국 증권의 예를 사용했습니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 Github에서 확인할 수 있습니다.

애널리스트 출처

Novanta Inc. 10 애널리스트 중 4 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Robert Mason	Baird
Ishan Majumdar	Baptista Research
Andrew Buscaglia	Berenberg

Novanta 배당금 및 환매

배당금 기준 확인 0/6

주요 정보

최근 배당금 및 환매 업데이트

Recent updates

Should You Think About Buying Novanta Inc. (NASDAQ:NOVT) Now?

Novanta Inc. to Report Q1, 2025 Results on May 06, 2025

Novanta: A Trusted Yet Premium Technology Partner

Novanta Inc.'s (NASDAQ:NOVT) Stock Retreats 27% But Earnings Haven't Escaped The Attention Of Investors

Investor sentiment deteriorates as stock falls 19%

There May Be Some Bright Spots In Novanta's (NASDAQ:NOVT) Earnings

CEO & Chairman of the Board exercised options and sold US$726k worth of stock

Novanta Inc. Provides Earnings Guidance for the First Quarter of 2025 and Full Year 2025

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Novanta Inc. to Report Q4, 2024 Results on Feb 25, 2025

Is Novanta (NASDAQ:NOVT) A Risky Investment?

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$151?

Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To Sell

Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price

Price target decreased by 9.0% to US$165

CEO & Chairman of the Board recently sold US$1.3m worth of stock

Third quarter 2024 earnings: EPS misses analyst expectations

Chief Financial Officer exercised options and sold US$582k worth of stock

Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 and Revenue Guidance for the Year 2025

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Novanta Inc. to Report Q3, 2024 Results on Nov 05, 2024

Chief Financial Officer notifies of intention to sell stock

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Chief Financial Officer exercised options and sold US$710k worth of stock

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc. Announces Executive Changes

Second quarter 2024 earnings: EPS misses analyst expectations

Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024

Chief Financial Officer exercised options and sold US$652k worth of stock

Now 26% overvalued after recent price rise

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta Inc. to Report Q2, 2024 Results on Aug 06, 2024

Chief Financial Officer notifies of intention to sell stock

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Novanta Inc. to Report Q1, 2024 Results on May 07, 2024

Price target increased by 11% to US$173

Novanta Inc., Annual General Meeting, May 08, 2024

CEO & Chairman of the Board exercised options and sold US$886k worth of stock

Novanta Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Novanta Inc. to Report Q4, 2023 Results on Feb 28, 2024

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

CEO & Chairman of the Board notifies of intention to sell stock

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Price target decreased by 8.5% to US$156

Investor sentiment improves as stock rises 18%

Novanta Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 and Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta Inc. to Report Q3, 2023 Results on Nov 07, 2023

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Chief Financial Officer notifies of intention to sell stock

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target increased by 7.6% to US$171

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Novanta Inc. to Report Q2, 2023 Results on Aug 08, 2023

CEO & Chairman of the Board notifies of intention to sell stock

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching